References
- Acosta-Montaño P, García-González V. 2018. Effects of dietary fatty acids in pancreatic beta cell metabolism, implications in homeostasis. Nutrients. 10(4):393. doi:10.3390/nu10040393.
- Currenti W, Buscemi S, Cincione RI, Cernigliaro A, Godos J, Grosso G, Galvano F. 2021. Time-restricted feeding and metabolic outcomes in a cohort of Italian adults. Nutrients. 202113(5):1651. doi:10.3390/nu13051651.
- Currenti W, Godos J, Castellano S, Mogavero MP, Ferri R, Caraci F, Grosso G, Galvano F. 2021. Time restricted feeding and mental health: a review of possible mechanisms on affective and cognitive disorders. Int J Food Sci Nutr. 72(6):723–733. doi:10.1080/09637486.2020.1866504.
- Food Processor Nutrition Analysis Software. 2018. Available from: https://www.esha.com/products/food-processor/
- Grosso G. 2021. Intermittent fasting: promising premises or broken promises? Int J Food Sci Nutr. 72(6):721–722. doi:10.1080/09637486.2021.1967301.
- Huang K, Liang Y, Wang K, Wu J, Luo H, Yi B. 2022. Influence of circulating nesfatin-1, GSH and SOD on insulin secretion in the development of T2DM. Front Public Health. 10:882686. doi:10.3389/fpubh.2022.882686.
- Karras SN, Koufakis T, Adamidou L, Dimakopoulos G, Karalazou P, Thisiadou K, Makedou K, Kotsa K. 2021. Effects of Christian Orthodox fasting versus time-restricted eating on plasma irisin concentrations among overweight metabolically healthy individuals. Nutrients. 13(4):1071. doi:10.3390/nu13041071.
- Karras SN, Koufakis T, Adamidou L, Dimakopoulos G, Karalazou P, Thisiadou K, Makedou K, Zebekakis P, Kotsa K. 2022. Implementation of Christian Orthodox fasting improves plasma adiponectin concentrations compared with time-restricted eating in overweight premenopausal women. Int J Food Sci Nutr. 73(2):210–220. doi:10.1080/09637486.2021.1941803.
- Koufakis T, Karras SΝ, Antonopoulou V, Angeloudi E, Zebekakis P, Kotsa K. 2017. Effects of Orthodox religious fasting on human health: a systematic review. Eur J Nutr. 201756(8):2439–2455. doi:10.1007/s00394-017-1534-8.
- Maejima Y, Horita S, Kobayashi D, Aoki M, O’hashi R, Imai R, Sakamoto K, Mori M, Takasu K, Ogawa K, et al. 2017. Nesfatin-1 inhibits voltage gated K+ channels in pancreatic beta cells. Peptides. 95:10–15. doi:10.1016/j.peptides.2017.07.001.
- Mirakhor Samani S, Ghasemi H, Rezaei Bookani K, Shokouhi B. 2019. SERUM NESFATIN-1 LEVEL IN HEALTHY SUBJECTS WITH WEIGHT-RELATED ABNORMALITIES AND NEWLY DIAGNOSED PATIENTS WITH TYPE 2 DIABETES MELLITUS; A CASE-CONTROL STUDY. Acta Endocrinol (Buchar). 5(1):69–73. doi:10.4183/aeb.2019.69.
- Nakata M, Manaka K, Yamamoto S, Mori M, Yada T. 2011. Nesfatin-1 enhances glucose-induced insulin secretion by promoting Ca(2+) influx through L-type channels in mouse islet β-cells. Endocr J. 58(4):305–313. doi:10.1507/endocrj.k11e-056.
- Sleiman D, Al-Badri MR, Azar ST. 2015. Effect of mediterranean diet in diabetes control and cardiovascular risk modification: a systematic review. Front Public Health. 3:69. doi:10.3389/fpubh.2015.00069.